TP53 and esophageal squamous cell carcinoma: Of all the identified mutated genes, genetic aberrations of TP53 are prevalent in 100% of the 12 ESCC cell lines (Fig. 3A, Fig. 3B) and 90% in ESCC patient tissue (Fig. 3C).